ArticleFrontiers in endocrinology2026
Sequence-specific radiomics for diagnosis of spinal bone loss.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To establish a sequence-specific predictive model for spinal bone loss by leveraging conventional lumbar MRI, targeting abnormal bone density or osteoporosis differentiations. Methods: A total of 320 MR scans from 160 patients (52 men and 108 women; mean age 61.27 ± 12.72 years) who underwent lumbar MRI and quantitative computed tomography (QCT) examinations were retrospectively enrolled in this study cohort. Radiomic features were extracted from the lumbar spine MR images. With QCT as the reference standard, six radiomic-based machine learning models including K-nearest neighbor (KNN), support vector machine (SVM), Linear Discriminant Analysis (LDA), logistic regression (LR), stochastic gradient descent (SGD), Gaussian NB were developed to predict abnormal bone density and osteoporosis using T1WI alone, T2WI alone, and the combined T1WI+T2WI. The dataset was randomly split into a training/validation set and a testing set in a 7:3 ratio. The performance metrics of the models were calculated and evaluated. Results: Among the six machine learning models evaluated, T1WI and T2WI each exhibited prominent advantages for predicting osteoporosis and abnormal bone mass, respectively. Take KNN as an example. T1WI achieved the highest AUC (0.821) for predicting osteoporosis on test set (mean of 10 repeated evaluations), significantly higher than T2WI (AUC = 0.782) and the combined T1WI+T2WI approach (AUC = 0.775). In contrast, T2WI demonstrated superior performance for the prediction of abnormal bone density, with an AUC of 0.942 (T1WI and T1WI+T2WI were 0.884 and 0.923, respectively). Conclusion: Our investigation into predicting abnormal bone density and osteoporosis from lumbar spine MRI sequences shows that predictive efficacy is sequence-dependent. T1WI features proved more effective for osteoporosis identification, while T2WI features were better for abnormal bone density prediction, highlighting the importance of sequence selection based on target pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.